Swedish CArdioPulmonary bioImage Study 2

Recruiting now

Conditions studied: Cardiovascular Diseases, Lung Diseases

In brief

In the Swedish CArdioPulmonary bioImage Study (SCAPIS 1), 30,154 randomly selected men and women, aged 50-64 years, were recruited from six areas in Sweden during 2013-2018. The study population was investigated with CCTA, ultrasound carotids, physical examination, questionnaires, accelerometry, ECG, spirometry, and biochemical markers. The aim was to obtain new information relevant to the identification and treatment of individuals with cardiopulmonary and metabolic diseases and to optimize the possibilities for studying disease mechanisms. In SCAPIS-2, half of the individuals (n≈15,000) included in SCAPIS 1, will be re-examined 2024-2025 with the same investigations as during 2013-2018 except for ultrasound of the carotids.

Key facts

Study ID

NCT06679777

Run by

Karolinska Institutet

People needed

30154

Starts

2024-01-15

Expected to finish

2030-12-31

Last updated by the study team

2024-11-07

Who can join

Age: any. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Participated in SCAPIS 1.

You may not qualify if…

• Individuals who have withdrawn their informed consent during or after SCAPIS 1.

Where it is running

• Gothenburg University — Gothenburg, Sweden (enrolling)
• Linköping University — Linköping, Sweden (enrolling)
• Lund University — Lund, Sweden (enrolling)
• Karolinska Institutet — Stockholm, Sweden (enrolling)
• Umeå Universitet — Umeå, Sweden (enrolling)
• Uppsala University — Uppsala, Sweden (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.